In the operation, TIM is supported by Chiomenti and Ropes & Gray; financial institutions are advised by Latham & Watkins. Telecom Italia – Tim has completed...
Telecom Italia – TIM’s €750 Million High Yield Bond Issuance
Novo Nordisk’s $2.7 Billion Drug Discovery Collaboration with Valo Health
Ropes & Gray advised Novo Nordisk on the deal. Novo Nordisk A/S and Valo Health, Inc. announced they have entered into an agreement to discover and...
The Baupost Group’s $50 Million Investment in Rail Modal Group
Ropes & Gray represented Baupost, while Sidley Austin acted as legal counsel to RMG for this transaction. Rail Modal Group announced the successful capital raise of $50...
SkyKnight Capital’s $1 Billion Fund IV Formation
Ropes & Gray advised SkyKnight on the fundraising. SkyKnight Capital, L.P. announced the final closing of SkyKnight Capital Fund IV, L.P., with $1 billion in commitments from...
BV Investment Partners’ $1.75 Billion Fund XI Formation
Ropes & Gray advised BV Investment Partners on the transaction. BV Investment Partners announced the closing of BV Investment Partners Fund XI. The fund closed at...
Trinseo’s $1.077 Billion Secured Term Loan Financing
Ropes & Gray advised Trinseo on the financing, and Paul Hastings advised Oaktree, Angelo Gordon and Apollo. Trinseo plc announced an innovative balance sheet optimization transaction addressing...
Xu v. Direxion Shares ETF Trust et al.
A Ropes & Gray litigation team secured a victory on behalf of Direxion Shares ETF Trust and its adviser, directors, and officers in a years-long dispute...
ImmunoGen’s Collaboration with Takeda
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into an exclusive collaboration with Takeda Pharmaceutical Company Limited (TSE:...
Nestlé’s Acquisition of Majority Stake in Grupo CRM
Ropes & Gray advised Advent International on the sale. Nestlé announced an agreement with Advent International to acquire a majority stake in Grupo CRM.. The transaction...
Verastem Oncology’s Collaboration with GenFleet Therapeutics
Ropes & Gray advised Verastem Oncology on the deal. Verastem Oncology (Nasdaq: VSTM) announced that the company has entered into a discovery and development collaboration with...
Cressey & Company’s Acquisition of HealthDrive
Ropes & Gray advised Bain Capital Double Impact on the sale. Cressey & Company LP announced that funds affiliated with Cressey have acquired HealthDrive from Bain Capital Double...
Genesis Therapeutics’ $200 Million Series B Funding Round
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...